The structure of a naphthalene derivative obtained by rearrangement of
13-methoxytotara-5,8,11,13-tetraen-7α-ol (2) has been revised to
5-(5′-isopropyl-6′-methoxy-2′-methyl-1′-naphthyl)-2-methylpent-2-ene
(7). A minor oxidation product of 13-methoxytotara-8,11,13-triene (4) has been
identified as
4-methoxy-3,3-dimethyl-7-(1′,3′,3′-trimethyl-2′-oxocyclohexanyl)isobenzofuran-1(3H)-one
(16) and its structure confirmed by X-ray crystallography. Methyl
12-methoxypodocarpa-8,11,13-trien-19-oate (12) has been converted into an
intermediate used in the synthesis of the linear diterpenoid umbrosone
[3-(1′-hydroxy-1′-methylethyl)-5,5,9-trimethyl-5,6,7,8-tetrahydroanthracene-1,2-dione]
(15).
通过重排 13-甲氧基托塔拉-5,8,11,13-四烯-7α-醇 (2) 而得到的
萘衍
生物的结构
13-甲氧基托塔拉-5,8,11,13-四烯-7α-醇 (2) 的结构已修订为
5-(5′-异丙基-6′-甲氧基-2′-甲基-1′-
萘基)-2-甲基戊-2-烯(7)。
(7).13-甲氧基托塔拉-8,11,13-
三烯(4)的一个次要氧化产物被确认为
确定为
4-甲氧基-3,3-二甲基-7-(1′,3′,3′-三甲基-2′-氧代环己基)
异苯并呋喃-1(3H)-酮(16)。
(16) 并通过 X 射线晶体学确认了其结构。甲基
12-甲氧基十二碳-8,11,13-
三烯-19-酸甲酯(12)已转化为一种
中间体,用于合成线性二萜
伞形酮
[3-(1′-羟基-1′-甲基乙基)-5,5,9-三甲基-5,6,7,8-四氢
蒽-1,2-二酮] (15) 的中间体。
(15).